SP
Seema Pandey
About Seema Pandey
Data last updated:
Seema Pandey has 2 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Ohe Pharmaceuticals Llp and Timing Minetech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Timing Minetech Private Limited at ₹4.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Jan 2024 | 2024 | ₹4.38 Cr (FY 2025) | Active | |
| Designated Partner | 09 Sep 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Seema Pandey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seema Pandey
Seema Pandey has 2 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Ohe Pharmaceuticals Llp and Timing Minetech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Timing Minetech Private Limited at ₹4.38 Cr (FY 2025).
Seema Pandey is associated with 2 companies as Designated Partner and Director, including Timing Minetech Private Limited (₹4.38 Cr), Ohe Pharmaceuticals Llp.
Seema Pandey has expertise in General Business, Technology.
Seema Pandey has 2 years in corporate governance.
By reported revenue, the largest current company of Seema Pandey is Timing Minetech Private Limited, with revenue of ₹4.38 Cr (FY 2025).
Seema Pandey currently holds positions at 2 companies: Timing Minetech Private Limited (₹4.38 Cr), Ohe Pharmaceuticals Llp.